✦ LIBER ✦

6-Months follow-up of 105 women treated with soy isoflavones because of a climacteric syndrome

Book ID: 118630682
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 141 KB
Volume: 3
Category: Article
ISSN: 1567-5688
DOI: 10.1016/s1567-5688(02)80127-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of whole soy and purified isoflav

Effect of whole soy and purified isoflavone daidzein on renal function—a 6-month randomized controlled trial in equol-producing postmenopausal women with prehypertension

✍ Liu, Zhao-min; Ho, Suzanne C.; Chen, Yu-ming; Tang, Nelson; Woo, Jean 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 369 KB

A mild favorable effect of soy protein w

A mild favorable effect of soy protein with isoflavones on body composition—a 6-month double-blind randomized placebo-controlled trial among Chinese postmenopausal women

✍ Liu, Z-m; Ho, S C; Chen, Y-m; Ho, Y P 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 373 KB

Validation of the GRACE Risk Score for P

Validation of the GRACE Risk Score for Predicting Death Within 6 Months of Follow-Up in a Contemporary Cohort of Patients With Acute Coronary Syndrome

✍ Emad Abu-Assi; José M. García-Acuña; Carlos Peña-Gil; José R. González-Juanatey 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 122 KB

Symptom persistence in a community cohor

Symptom persistence in a community cohort of women with interstitial cystitis/bladder pain syndrome (IC/BPS): 3-, 6-, 9-, and 12-month follow-up from the RICE cohort

✍ Suskind, Anne M.; Berry, Sandra H.; Suttorp, Marika J.; Elliott, Marc N.; Clemen 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 143 KB

Pharmacokinetic study of a high-purity f

Pharmacokinetic study of a high-purity factor IX concentrate (Factor IX Grifols®) with a 6-month follow up in previously treated patients with severe haemophilia B

✍ J. A. AZNAR; N. CABRERA; M. MATYSIAK; K. ZAWILSKA; L. GERCHEVA; A. ANTONOV; M. M 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Biochemical and virological outcome of p

Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: A 4-year follow-up of 211 patients

✍ E K Manesis; C Papaioannou; A Gioustozi; G Kafiri; J Koskinas; S J Hadziyannis 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 2 views

To compare two interferon (IFN) schedules for the treatment of chronic hepatitis C, we followed 211 patients who received 3 million units IFN-alpha2b thrice weekly for either 6 months (group 1; 85 patients) or 12 months (group 2; 126 patients), with a median follow-up of 3.4 (0.1-8.4) and 4.2 (0.7-8